Additionally, mast cells with low BTG2 expression could induce an increased proportion of αSMA-positive myofibroblasts, which enhance tumor invasiveness and metastatic potential by altering the glycosylation patterns of tumor cells. Here, BTG2 is linked to neoplasm.